Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone AAV2E9Q3) SynExpress SP-Cy3-I10-E Modified CD8+ T cells (CAT#: ITS-1224-CR298)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone AAV2E9Q3). We employs the Lentivirus (SP6-Cy3-IL-10-EcoRI) vector components and the SynExpress system of the Exons Knockout/Positive feedback for a robust and sustained response against cancers.
Host
human
Target
CCL2
Clone
AAV2E9Q3
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
SP6
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.88
Cell Culture
Adherent Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving